Abstract
The Biopharmaceuticals Laboratory has a tradition in the discovery, development and characterization of monoclonal antibodies with therapeutic potential for infectious diseases. Recently, the laboratory produced and characterized a variety of human anti-tetanus and anti-Sars-Cov-2 antibodies in their integral format, that is, complete IgG. However, there was a need to produce and study an…